Cite
APA Citation
Harnden, A., Huckvale, R., Cheung, K., Davis, O., Pierrat, O., Talbot, R., Box, G., Bright, M., Akpinar, A., Miller, D., Hayes, A., Gunnell, E., Le Bihan, Y., Burke, R., Kirkin, V., Van Montfort, R., Raynaud, F., Rossanese, O., Bellenie, B., & Hoelder, S. (n.d.). improved binding affinity and pharmacokinetics enables sustained degradation of BCL6 in vivo. European journal of cancer, 174, S104–. http://access.bl.uk/ark:/81055/vdc_100168600408.0x000033